FERRING LÆGEMIDLER A/S: Financial statements 2012
CVR: 16313491
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
FERRING LÆGEMIDLER A/S (CVR 16313491) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 18,984,000 and a net result of DKK 2,141,000. Equity in the 2012 report amounted to DKK 9,876,000. The solvency ratio was 55.1%.
- Gross Profit
- DKK 18,984,000
- Profit/Loss
- DKK 2,141,000
- Equity
- DKK 9,876,000
- Total Assets
- DKK 17,930,000
Official annual report
Keep an eye on FERRING LÆGEMIDLER A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of January 1, 2012, Carl Erik Johan Mastrell is registered as adm. dir. of FERRING LÆGEMIDLER A/S.
As of January 1, 2012, Anders Månsson has stepped down as adm. dir. of FERRING LÆGEMIDLER A/S.
About FERRING LÆGEMIDLER A/S
FERRING LÆGEMIDLER A/S is a Danish company of the type Aktieselskab based in Kastrup, founded in 1992. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named A/S PSE 38 NR. 1586. The management consists of Maja Lassenius Kramp. The board consists of Kjell Thomas Larsson (chair), Eric Michel Breumier and Valerio Trifoni. The company is owned by Ferring B.V.. The company has 17 employees (2026). In 2025, the company reported a gross profit of DKK 6,653,000 and a net result of DKK 1,371,000 compared with DKK 1,234,000 the year before. Equity in the 2025 report amounted to DKK 11,229,000.